Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rasmussen's encephalitis.

Yvonne Hart1

  • 1Radcliffe Infirmary, Oxford, UK. yvonne.hart@orh.nhs.uk

Epileptic Disorders : International Epilepsy Journal with Videotape
|December 4, 2004
PubMed
Summary
This summary is machine-generated.

Rasmussen's encephalitis causes progressive neurological decline in children. Recent research explores immune system roles in its cause and treatment, moving beyond earlier viral theories.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Woman With Intellectual Disability, Amenorrhoea, Seizures, and Balance Problems.

JAMA neurology·2016
Same author

Rasmussen encephalitis and comorbid autoimmune diseases: A window into disease mechanism?

Neurology·2014
Same author

Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy.

Epilepsia·2013
Same author

Epilepsy after subarachnoid hemorrhage: the frequency of seizures after clip occlusion or coil embolization of a ruptured cerebral aneurysm: results from the International Subarachnoid Aneurysm Trial.

Journal of neurosurgery·2011
Same author

Epilepsy and the subsequent risk of cerebral tumour: record linkage retrospective cohort study.

Journal of neurology, neurosurgery, and psychiatry·2011
Same author

Levetiracetam: an innovative and cost-effective add-on drug for refractory partial epilepsy.

Expert review of pharmacoeconomics & outcomes research·2009
Same journal

Misinformation about seizures and epilepsy on the web: The need for systematic quality management.

Epileptic disorders : international epilepsy journal with videotape·2026
Same journal

Expanding the spectrum of generalized periodic discharges with triphasic morphology in nonconvulsive status epilepticus.

Epileptic disorders : international epilepsy journal with videotape·2026
Same journal

Epilepsy and vascular risk: Evaluation of the influence of antiseizure medications on atherosclerotic disease.

Epileptic disorders : international epilepsy journal with videotape·2026
Same journal

Adult-onset CD8-predominant hemispheric inflammatory epilepsy: Expanding the spectrum of post-infectious and Rasmussen-like encephalitis.

Epileptic disorders : international epilepsy journal with videotape·2026
Same journal

Cenobamate use in super-refractory status epilepticus: A report of three cases.

Epileptic disorders : international epilepsy journal with videotape·2026
Same journal

Exploring the efficacy and safety of perampanel in epilepsia partialis continua: A case series.

Epileptic disorders : international epilepsy journal with videotape·2026
See all related articles

Area of Science:

  • Neurology
  • Immunology
  • Pediatrics

Background:

  • Rasmussen's encephalitis, a rare neurological syndrome, presents in children with seizures, hemiparesis, and cognitive decline.
  • First described 50 years ago, its etiology and optimal treatment remain incompletely understood.
  • Historically presumed viral, recent focus has shifted to immune-mediated mechanisms.

Purpose of the Study:

  • To review the clinical features of Rasmussen's encephalitis.
  • To discuss evolving theories on its pathogenesis, including antibody-mediated and cell-mediated immunity.
  • To assess recent advances in treatment strategies.

Main Methods:

  • Literature review of clinical features.
  • Discussion of immunological findings.

Related Experiment Videos

  • Assessment of treatment outcomes.

    • Main Results:

    • Clinical presentation includes partial motor seizures, progressive hemiparesis, cognitive impairment, and unilateral cerebral atrophy.
    • Evidence increasingly points towards immune system dysregulation, rather than solely viral infection, in pathogenesis.
    • Treatment advances are being explored in conjunction with a better understanding of the disease mechanisms.

    Conclusions:

    • The pathogenesis of Rasmussen's encephalitis is likely complex and involves immune system components.
    • Further research into immunological mechanisms is crucial for developing effective treatments.
    • A comprehensive understanding of clinical features and evolving treatment strategies is essential for patient care.